Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase 1 Dose Escalation and Expansion Study of PRAME T Cell Receptor (TCR) Engineered NK Cells in Participants With Recurrent and/or Refractory Melanoma (PRAMETIME-Mel)
Apply
PRAME TCR NK Cells
Phase 1 Dose Escalation and Expansion Study of PRAME T Cell Receptor (TCR) Engineered NK Cells in Participants With Recurrent and/or Refractory Melanoma (PRAMETIME-Mel)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step